Accesso libero

Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor

Vida Gavric Lovrec

Lovrec, Vida Gavric

,

e

22 dic 2021

Cervix-Online computer program: 27 years of hospital-based clinical registry for cervical cancer at the University Medical Centre Maribor's Cover Image

Radiology and Oncology

Volume 56 (2022): Numero 2 (Giugno 2022)

INFORMAZIONI SU QUESTO ARTICOLO

Articolo precedente

Articolo Successivo

Cita

CONDIVIDI

Scarica la copertina

Categoria dell'articolo: Research Article

Pubblicato online: 22 dic 2021

Pagine: 198 - 207

Ricevuto: 13 set 2021

Accettato: 22 nov 2021

DOI: https://doi.org/10.2478/raon-2021-0054

Parole chiave
hospital-based clinical registry, computer program, cervical cancer

© 2022 Vida Gavric Lovrec, Darja Arko, Iztok Takac, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

General data.
CT = chemotherapy; RT = radiotherapy — General data. CT = chemotherapy; RT = radiotherapy

Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage).
AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified — Medical history, clinical examination, clinical stage (preoperative International Federation of Gynecology and Obstetrics [FIGO] stage). AGC - neoplastic = atypical glandular cells - neoplastic; AGC-NOS = atypical glandular cells - not otherwise specified; AIS = adenocarcinoma in situ; AC = adenocarcinoma; ASC-US = atypical squamous cells - of undetermined significance; ASC-H = atypical squamous cells - cannot exclude HSIL; GIT = gastrointestinal tract; HGSIL = high grade squamous intraepithelial lesion; IUD = intrauterine device; IUS = intrauterine system; LGSIL = low grade squamous intraepithelial lesion; MLG-N = other malignant cells - inevaluable; MTOP = medical termination of pregnancy; N/A = not available; SCC = squamous cell carcinoma; SFM-NOS = suspicious for malignancy - not otherwise specified

Tests at initial examination.
CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen — Tests at initial examination. CEA = carcinoembryonic antigen; L = left; NAD = no evidence of disease; R = right; SCC = squamous cell carcinoma antigen

Treatment.
CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor — Treatment. CT = chemotherapy: DVT = deep vein thrombosis; G-CSF = granulocyte colony stimulating factor

Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology.
L = left; R = right — Histopathology, International Federation of Gynecology and Obstetrics (FIGO) stage after definitive histology. L = left; R = right

Chemotherapy cycles.
CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen — Chemotherapy cycles. CEA = carcinoembryonic antigen; G-CSF = granulocyte colony stimulating factor; NAD = nothing abnormal detected; SCC = squamous cell carcinoma antigen

Follow-up form.
TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection — Follow-up form. TH = therapy; NAD = nothing abnormal detected; ASC-US = atypical squamous cells of undetermined significance; ASC-H = atypical squamous cells – cannot exclude HSIL; LGSIL = low-grade squamous intraepithelial lesion ; HGSIL = high grade squamous intraepithelial lesion; SCC = squamous cell carcinoma; AGC-NOS = atypical glandular cells not otherwise specified; AGC-neoplastic = atypical glandular cells, suspicious for AIS or cancer; AIS = adenocarcinoma in situ; AC = adenocarcinoma; SFM-NOS = suspicious for malignancy; MLG-N = malignancy; SCC = squamous cell carcinoma antigen; CEA = carcinoembryonic antigen; UTI = urinary tract infection

Lingua:: Inglese

Frequenza di pubblicazione:: 4 volte all'anno
Argomenti della rivista:: Medicina, Medicina clinica, Medicina interna, Ematologia, Oncologia, Radiologia

Feed RSS della rivista